IDEXX director granted RSUs and stock options

IDEXX Laboratories director Sophie V. Vandebroek reported equity compensation grants in the form of restricted stock units and stock options.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

IDEXX Laboratories director Sophie V. Vandebroek reported equity compensation grants in the form of restricted stock units and stock options. She received 234 restricted stock units, each representing one share of common stock, and 525 non-qualified stock options with an exercise price of $533.92 per share. Both the units and options vest in a single installment on the one-year anniversary of the grant date or on the date of the 2027 annual meeting of shareholders, whichever comes earlier.

Insider Trade Summary

Grant/Award: 759 shares

Grant/Award 2 txns

Insider Vandebroek Sophie V.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Non-Qualified Stock Option (right-to-buy)	525	$0.00	$0.00
Grant/Award	Restricted Stock Unit	234	$0.00	$0.00

Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 525 contracts (Direct); Restricted Stock Unit — 234 contracts (Direct)

Footnotes (2)

F1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
F2. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.

Key Figures

Restricted stock units granted: 234 units Stock options granted: 525 options Option exercise price: $533.92 per share +3 more

6 metrics

Restricted stock units granted 234 units Director equity award granted on May 12, 2026

Stock options granted 525 options Non-qualified stock option award to director

Option exercise price $533.92 per share Non-qualified stock option strike price

Option expiration May 11, 2036 Expiration date of non-qualified stock options

Underlying shares for RSUs 234 shares Each RSU equals one IDEXX common share

Underlying shares for options 525 shares Shares purchasable upon option exercise

Key Terms

Restricted Stock Unit, Non-Qualified Stock Option (right-to-buy), contingent right, annual meeting of shareholders

4 terms

Restricted Stock Unit financial

"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Non-Qualified Stock Option (right-to-buy) financial

"Grant of option to buy shares of Issuer common stock that vest in one installment."

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share of Issuer common stock."

annual meeting of shareholders financial

"Vests on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders."

A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What equity awards did Sophie V. Vandebroek receive from IDEXX (IDXX)?

Sophie V. Vandebroek received 234 restricted stock units and 525 non-qualified stock options. Each restricted stock unit represents one share of IDEXX common stock, and the options have a fixed exercise price and stated expiration date as director compensation.

What is the exercise price of Sophie Vandebroek’s new IDEXX (IDXX) stock options?

The non-qualified stock options granted to Sophie Vandebroek have an exercise price of $533.92 per share. This is the price she must pay to purchase each share of IDEXX common stock if she chooses to exercise the options in the future.

When do Sophie Vandebroek’s IDEXX (IDXX) restricted stock units and options vest?

Both the restricted stock units and stock options vest in a single installment. Vesting occurs on the one-year anniversary of the grant date or on the date of the 2027 annual meeting of shareholders, whichever event happens earlier according to the award terms.

How many IDEXX (IDXX) restricted stock units does Sophie Vandebroek hold after this Form 4?

After this grant, Sophie Vandebroek holds 234 restricted stock units related to the reported award. Each unit represents a contingent right to receive one share of IDEXX common stock, subject to the specified vesting conditions being satisfied over time.

How many IDEXX (IDXX) stock options does Sophie Vandebroek hold from this grant?

From this reported grant, Sophie Vandebroek holds 525 non-qualified stock options. These options give her the right to buy up to 525 shares of IDEXX common stock at an exercise price of $533.92 per share if exercised before expiration.

What is the expiration date of Sophie Vandebroek’s new IDEXX (IDXX) stock options?

The granted non-qualified stock options expire on May 11, 2036. If the options are not exercised by that expiration date, they will lapse and no longer provide the right to purchase IDEXX common stock at the specified exercise price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 05/14/2026 - 05:01 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Vandebroek Sophie V.

(Last)

(First)

(Middle)

ONE IDEXX DRIVE

(Street)

WESTBROOK

MAINE

04092

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Non-Qualified Stock Option (right-to-buy)	$533.92	05/12/2026		A		525		⁽¹⁾	05/11/2036	Common Stock	525	$0	525	D
Restricted Stock Unit	⁽²⁾	05/12/2026		A		234		⁽²⁾	⁽²⁾	Common Stock	234	$0	234	D

Explanation of Responses:

1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.

2. Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. These restricted stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.

Remarks:

	/s/ Lily J. Lu, Attorney-in-Fact for Sophie V. Vandebroek	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR